Crinetics Pharmaceuticals (CRNX) Other Gross PP&E Adjustments (2017 - 2025)
Crinetics Pharmaceuticals (CRNX) has 9 years of Other Gross PP&E Adjustments data on record, last reported at -$41.7 million in Q4 2025.
- For Q4 2025, Other Gross PP&E Adjustments changed 0.32% year-over-year to -$41.7 million; the TTM value through Dec 2025 reached -$41.7 million, changed 0.32%, while the annual FY2025 figure was -$41.7 million, 0.32% changed from the prior year.
- Other Gross PP&E Adjustments reached -$41.7 million in Q4 2025 per CRNX's latest filing, down from -$19.7 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $6.6 million in Q2 2023 and bottomed at -$42.8 million in Q4 2023.
- Average Other Gross PP&E Adjustments over 5 years is -$13.4 million, with a median of -$9.9 million recorded in 2022.
- Peak YoY movement for Other Gross PP&E Adjustments: soared 360.51% in 2022, then tumbled 1967.97% in 2023.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at -$1.5 million in 2021, then crashed by 39.3% to -$2.1 million in 2022, then crashed by 1967.97% to -$42.8 million in 2023, then rose by 2.36% to -$41.8 million in 2024, then rose by 0.32% to -$41.7 million in 2025.
- Per Business Quant database, its latest 3 readings for Other Gross PP&E Adjustments were -$41.7 million in Q4 2025, -$19.7 million in Q3 2025, and -$17.6 million in Q2 2025.